Target Profile Prediction: Cross-Activation of Peroxisome Proliferator-Activated Receptor (PPAR) and Farnesoid X Receptor (FXR)
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Target Profile Prediction: Cross-Activation of Peroxisome Proliferator-Activated Receptor (PPAR) and Farnesoid X Receptor (FXR)
Authors
Keywords
-
Journal
Molecular Informatics
Volume 29, Issue 4, Pages 287-292
Publisher
Wiley
Online
2010-02-20
DOI
10.1002/minf.200900009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Self-organizing molecular fingerprints: a ligand-based view on drug-like chemical space and off-target prediction
- (2010) Gisbert Schneider et al. Future Medicinal Chemistry
- FXR agonist activity of conformationally constrained analogs of GW 4064
- (2009) Adwoa Akwabi-Ameyaw et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
- (2009) Enrique Z Fisman et al. Cardiovascular Diabetology
- Homology Model Adjustment and Ligand Screening with a Pseudoreceptor of the Human Histamine H4Receptor
- (2009) Yusuf Tanrikulu et al. ChemMedChem
- PPAR activators and COX inhibitors selectively block cytokine-induced COX-2 expression and activity in human aortic smooth muscle cells
- (2009) Yves Rival et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Chemokine receptor antagonists: part 2
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Chemokine receptor antagonists: Part 1
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Bias-Correction of Regression Models: A Case Study on hERG Inhibition
- (2009) Katja Hansen et al. Journal of Chemical Information and Modeling
- Differential Modulation of Farnesoid X Receptor Signaling Pathway by the Thiazolidinediones
- (2009) R. Kaimal et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Activation of peripheral κ/δ opioid receptors mediates 15-deoxy-Δ12,14-prostaglandin J2 induced-antinociception in rat temporomandibular joint
- (2009) D.R. Pena-Dos-Santos et al. NEUROSCIENCE
- Self-Organizing Maps in Drug Discovery: Compound Library Design, Scaffold-Hopping, Repurposing
- (2008) P. Schneider et al. CURRENT MEDICINAL CHEMISTRY
- Computational analysis of ligand relationships within target families
- (2008) Jürgen Bajorath CURRENT OPINION IN CHEMICAL BIOLOGY
- Mechanisms Underlying Pioglitazone-Mediated Relaxation in Isolated Blood Vessel
- (2008) Hidemi Nomura et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening
- (2008) Yusuf Tanrikulu et al. NATURE REVIEWS DRUG DISCOVERY
- The hERG K+ channel: target and antitarget strategies in drug development
- (2008) Emanuel Raschi et al. PHARMACOLOGICAL RESEARCH
- The PPARγ agonist FMOC-l-leucine protects both mature and immature brain
- (2007) Pierre Maurois et al. BIOMEDICINE & PHARMACOTHERAPY
- A Composite Model for hERG Blockade
- (2007) Christian Kramer et al. ChemMedChem
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search